Midnolin is a novel regulator of parkin expression and is associated with Parkinson’s Disease

[1]  M. Brini,et al.  Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness. , 2017, Biochemical and biophysical research communications.

[2]  A. Nairn.  Faculty of 1000 evaluation for GDNF, NGF and BDNF as therapeutic options for neurodegeneration. , 2016 .

[3]  W. Nemoto,et al.  ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells. , 2016, Cellular signalling.

[4]  H. Ariga.  Common mechanisms of onset of cancer and neurodegenerative diseases. , 2015, Biological & pharmaceutical bulletin.

[5]  Y. Obara,et al.  Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription , 2015, PloS one.

[6]  S. Baltrusch,et al.  Identification of the Ubiquitin-like Domain of Midnolin as a New Glucokinase Interaction Partner* , 2013, The Journal of Biological Chemistry.

[7]  N. Patel,et al.  GDNF, NGF and BDNF as therapeutic options for neurodegeneration. , 2013, Pharmacology & therapeutics.

[8]  L. Greene,et al.  ATF4 Protects Against Neuronal Death in Cellular Parkinson's Disease Models by Maintaining Levels of Parkin , 2013, The Journal of Neuroscience.

[9]  P. Maher,et al.  Mutation of ATF4 mediates resistance of neuronal cell lines against oxidative stress by inducing xCT expression , 2011, Cell Death and Differentiation.

[10]  S. Koyama,et al.  Authentically Phosphorylated α-Synuclein at Ser129 Accelerates Neurodegeneration in a Rat Model of Familial Parkinson's Disease , 2011, The Journal of Neuroscience.

[11]  David S. Park,et al.  Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress , 2011, Cell Death and Differentiation.

[12]  W. Nemoto,et al.  Basic fibroblast growth factor promotes glial cell-derived neurotrophic factor gene expression mediated by activation of ERK5 in rat C6 glioma cells. , 2011, Cellular signalling.

[13]  David S. Park,et al.  Neuronal Apoptosis Induced by Endoplasmic Reticulum Stress Is Regulated by ATF4–CHOP-Mediated Induction of the Bcl-2 Homology 3-Only Member PUMA , 2010, The Journal of Neuroscience.

[14]  Y. Obara,et al.  The Signaling Pathway Leading to Extracellular Signal-Regulated Kinase 5 (ERK5) Activation via G-Proteins and ERK5-Dependent Neurotrophic Effects , 2010, Molecular Pharmacology.

[15]  Keiji Tanaka,et al.  Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease? , 2010, Journal of Alzheimer's disease : JAD.

[16]  W. Nemoto,et al.  ERK5 Activity Is Required for Nerve Growth Factor-induced Neurite Outgrowth and Stabilization of Tyrosine Hydroxylase in PC12 Cells* , 2009, The Journal of Biological Chemistry.

[17]  R. Takahashi,et al.  Pael‐R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss , 2008, Journal of neurochemistry.

[18]  Giovanni Coppola,et al.  ATF4 is an oxidative stress–inducible, prodeath transcription factor in neurons in vitro and in vivo , 2008, The Journal of experimental medicine.

[19]  P. Coussens,et al.  Differential expression of genes for transcription factors in theca and granulosa cells following selection of a dominant follicle in cattle , 2008, Molecular reproduction and development.

[20]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[21]  P. Stork,et al.  The requirement of Ras and Rap1 for the activation of ERKs by cAMP, PACAP, and KCl in cerebellar granule cells , 2007, Journal of neurochemistry.

[22]  W. Scheper,et al.  Activation of the unfolded protein response in Parkinson's disease. , 2007, Biochemical and biophysical research communications.

[23]  T. Iwatsubo,et al.  The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease , 2006, The Journal of Neuroscience.

[24]  P. Stork,et al.  PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells , 2004, Journal of Cell Science.

[25]  Bryan L Roth,et al.  Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* , 2003, Journal of Biological Chemistry.

[26]  Santiago Canals,et al.  Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. , 2003, Human molecular genetics.

[27]  E. Kandel,et al.  Rap1 Couples cAMP Signaling to a Distinct Pool of p42/44MAPK Regulating Excitability, Synaptic Plasticity, Learning, and Memory , 2003, Neuron.

[28]  P. Lockhart,et al.  Identification of a novel gene linked to parkin via a bi-directional promoter. , 2003, Journal of molecular biology.

[29]  A. Markus,et al.  Neurotrophic factors and axonal growth , 2002, Current Opinion in Neurobiology.

[30]  A. Mungall,et al.  The genomic structure and promoter region of the human parkin gene. , 2001, Biochemical and biophysical research communications.

[31]  N. Hattori,et al.  An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.

[32]  H. Suemori,et al.  Novel nucleolar protein, midnolin, is expressed in the mesencephalon during mouse development. , 2000, Gene.

[33]  E. Mccleskey,et al.  Rap1 mediates sustained MAP kinase activation induced by nerve growth factor , 1998, Nature.